Overview
PRCT market data
Price History
PRCT price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.72 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.94 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -32.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $16.67 – $42.71 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.3B · P/B 4.80 · P/S 3.73.
Company News
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors with Significant Losses to Contact the Firm Before September 22, 2026Globenewswire Inc · Aug 7, 2026, 3:15 PM
TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28Benzinga · Aug 5, 2026, 7:44 PM
Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25Benzinga · Aug 5, 2026, 4:00 PM
Evercore ISI Group Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $23Benzinga · Aug 5, 2026, 2:22 PM
William Blair Downgrades PROCEPT BioRobotics to Market PerformBenzinga · Aug 5, 2026, 10:55 AM
PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $397.424M EstBenzinga · Aug 4, 2026, 8:16 PM
8-K filing — PROCEPT BioRobotics Corp (PRCT)SEC EDGAR · Aug 4, 2026, 8:12 PM
PROCEPT BioRobotics Q2 EPS $(0.47) Misses $(0.46) Estimate, Sales $94.498M Beat $92.893M EstimateBenzinga · Aug 4, 2026, 8:06 PM
Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your BehalfGlobenewswire Inc · Aug 4, 2026, 4:15 PM
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application DeadlineGlobenewswire Inc · Jul 29, 2026, 11:00 AM